-
3 weeks ago | 
pharmaceuticalcommerce.com | Michael Hollan
On Sunday, President Trump posted to Truth Social that he planned on implementing a most-favored-nation policy for pharmaceutical drug prices.
-
2 months ago | 
pharmexec.com | Michael Hollan
The Project Farma president discusses various ways the tariffs could impact the industry and how businesses can prepare or react.
-
Feb 24, 2025 | 
pharmexec.com | Michael Hollan
John Arena, interim president of global pharma services at Cencora, discusses how new technologies are shortening timelines.
-
Jul 2, 2024 | 
yourtango.com | Michael Hollan
We all want to be better people. It's a good thing, because it means most of us are trying to grow. That's the biggest part of being a good person: simply trying every once in a while. It all comes down to the little things. While it would be great if everyone could give up their worldly possessions and become community farmers and doctors, that's just not realistic. We all have lives to live and we can't just drop everything. But we can improve our day-to-day lives.
-
Apr 18, 2024 | 
cbr.com | Jordan Iacobucci |Michael Hollan |Anthony Jeanetta
By Jordan Iacobucci , Michael Hollan , and Anthony Jeanetta Updated 15 minutes ago He might be considered the king of the monsters, but there are plenty of other movie beasts that could dethrone Godzilla and steal the crown.
-
Mar 23, 2024 | 
yourtango.com | Michael Hollan
I'm the middle child of three boys. All my life, I’ve heard people tell me, "I can tell that you're a middle child." It's the hardest position to grow up in, and you may develop middle-child syndrome. Oldest and youngest siblings have well-defined characteristics due to birth order, but the middle child is a real wild card. That said, if you’re dating a middle child, you might not know how to deal with them. But here are 11 things you'll always find to be true.
-
Mar 17, 2024 | 
yourtango.com | Michael Hollan
Nothing, especially polyamory, is going to be able to fix your broken marriage. By Michael Hollan Last updated on Mar 17, 2024Photo: Robert Kneschke, rashadashurov, Jona_al | Canva Editor's Note: This is a part of YourTango's Opinion section where individual authors can provide varying perspectives for wide-ranging political, social, and personal commentary on issues. Would going to an intimate party with your spouse save your marriage? According to expert Louise Van der Velde, it definitely will.
-
Feb 13, 2024 | 
pharmaceuticalcommerce.com | Michael Hollan
Novo Nordisk’s parent company recently announced that it has agreed to purchase Catalent. As part of the acquisition, Novo Nordisk will purchase three of Catalent’s manufacturing sites. This is part of a move by the company to increase its ability to meet the demand for Wegovy, a highly popular weight loss drug. Bruce Phelan, senior partner at Blue Fin, spoke with Pharmaceutical Executive about the larger impact that this purchase will have on the industry.
-
Feb 13, 2024 | 
pharmaceuticalcommerce.com | Michael Hollan
Artificial intelligence (AI) is hitting pharma’s budgets, but not in the way you think. A new survey of pharma executives looked into the ways which pharma companies are incorporating AI into their business plans.1 According to the results, a significant number of pharma leaders are already so confident in the results that technology like generative AI can achieve that they’re adjusting their budgets.
-
Feb 9, 2024 | 
pharmaceuticalcommerce.com | Michael Hollan
The generic drug market is expected to show significant growth in the coming years. At least, that’s according to a new study conducted by Technavio, a leading global technology research and advisory company.1 In a press release, the research company detailed the estimated growth, stating that it believes the market will grow by $176.25 billion by 2027. It also states that North America will contribute about 37% of this growth.
